Home/Pataigin/David Goodlett
DG

David Goodlett

Co-Founder, Professor

Pataigin

Therapeutic Areas

Pataigin Pipeline

DrugIndicationPhase
BACLIB Microbial IDRapid identification of bacteria and fungiRUO / Development
BACLIB for AMRDetection of antimicrobial resistance (e.g., colistin resistance)Research